創業健康壽命競賽
XPRIZE 公布其競賽20支決賽隊伍
XPRIZE 是一家以策劃及營運大型獎金競賽應對全球重大挑戰而聞名的非牟利機構，宣布其總獎金達 1.01 億美元的 XPRIZE Healthspan 競賽已選出 20 支入圍隊伍。這項活動旨在加速開發針對衰老生物機制的普及療法，目標是在治療後一年或更短時間內，讓 50 至 90 歲成年人的肌肉、認知及免疫功能回復至少 10 年，理想情況下達 20 年之久。其中十支隊伍各獲頒 100 萬美元里程碑獎金，以支持其臨床測試工作。
XPRIZE Healthspan 競賽的入圍隊伍分別來自美國、南韓、日本及中國，正採用多種多樣的科學策略——由針對新陳代謝、發炎及組織修復的舊藥重新利用或新藥開發，到針對細胞損傷及纖維化的生物治療方案，涵蓋範疇甚廣。
英文原文
XPRIZE, a nonprofit organization known for designing and operating large-scale incentive competitions to address major global challenges, has announced the 20 finalist teams advancing in its $101 million XPRIZE Healthspan competition. This activation aims to accelerate the development of accessible therapeutics that target the biological processes of aging, with the goal of restoring muscle, cognitive, and immune function in adults aged 50 to 90 by at least 10 years, and ideally 20 years, within one year or less of treatment. Ten of these teams have each received a $1 million milestone award to support their clinical testing efforts.
The XPRIZE Healthspan competition finalist teams, representing the United States, South Korea, Japan, and China, are pursuing a wide array of scientific strategies — from repurposed or new drugs that address metabolism, inflammation, and tissue repair to biologic treatments that disrupt cellular damage and fibrosis, and so much more.
- 來源
- Trend Hunter
- 發布
- 2026-08-14
- 品類
- Inventions
- 出處
- prnewswire